欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2331/002
药品名称Airfonsib
活性成分
    • beclometasone dipropionate 200.0 µg/dose
    • Formoterolfumarat dihydrate 6.0 µg/dose
剂型Pressurised inhalation, solution
上市许可持有人Sandoz A/S Edvard Thomsens Vej 14, 2300, Copenhagen S, Denmark
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Denmark (DK)
    • Romania (RO)
    • Netherlands (NL)
    • Slovakia (SK)
    • France (FR)
    • Slovenia (SI)
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
    • Latvia (LV)
    • Estonia (EE)
    • Croatia (HR)
    • Czechia (CZ)
      Airfonsib
    • Germany (DE)
      BecloFormAir
    • Hungary (HU)
许可日期2024/04/29
最近更新日期2024/05/20
药物ATC编码
    • R03AK08 formoterol and beclometasone
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase